-
1
-
-
60749083864
-
Treatment outcomes among patients with multidrug-resistant tuberculosis: Systematic review and meta-analysis
-
Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP. 2009. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect. Dis. 9:153-161.
-
(2009)
Lancet Infect. Dis.
, vol.9
, pp. 153-161
-
-
Orenstein, E.W.1
Basu, S.2
Shah, N.S.3
Andrews, J.R.4
Friedland, G.H.5
Moll, A.P.6
Gandhi, N.R.7
Galvani, A.P.8
-
2
-
-
36849040101
-
Clinical and operational value of the extensively drug-resistant tuberculosis definition
-
Migliori GB, Besozzi G, Girardi E, Kliiman K, Lange C, Toungoussova OS, Ferrara G, Cirillo DM, Gori A, Matteelli A, Spanevello A, Codecasa LR, Raviglione MC. 2007. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur. Respir. J. 30:623-626.
-
(2007)
Eur. Respir. J.
, vol.30
, pp. 623-626
-
-
Migliori, G.B.1
Besozzi, G.2
Girardi, E.3
Kliiman, K.4
Lange, C.5
Toungoussova, O.S.6
Ferrara, G.7
Cirillo, D.M.8
Gori, A.9
Matteelli, A.10
Spanevello, A.11
Codecasa, L.R.12
Raviglione, M.C.13
-
3
-
-
56149108209
-
Extensively drug-resistant tuberculosis in the United States, 1993-2007
-
Shah NS, Pratt R, Armstrong L, Robison V, Castro KG, Cegielski JP. 2008. Extensively drug-resistant tuberculosis in the United States, 1993-2007. JAMA 300:2153-2160.
-
(2008)
JAMA
, vol.300
, pp. 2153-2160
-
-
Shah, N.S.1
Pratt, R.2
Armstrong, L.3
Robison, V.4
Castro, K.G.5
Cegielski, J.P.6
-
4
-
-
49249098575
-
Comprehensive treatment of extensively drug-resistant tuberculosis
-
Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HSF, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC. 2008. Comprehensive treatment of extensively drug-resistant tuberculosis. N. Engl. J. Med. 359: 563-574.
-
(2008)
N. Engl. J. Med.
, vol.359
, pp. 563-574
-
-
Mitnick, C.D.1
Shin, S.S.2
Seung, K.J.3
Rich, M.L.4
Atwood, S.S.5
Furin, J.J.6
Fitzmaurice, G.M.7
Alcantara Viru, F.A.8
Appleton, S.C.9
Bayona, J.N.10
Bonilla, C.A.11
Chalco, K.12
Choi, S.13
Franke, M.F.14
Fraser, H.S.F.15
Guerra, D.16
Hurtado, R.M.17
Jazayeri, D.18
Joseph, K.19
Llaro, K.20
Mestanza, L.21
Mukherjee, J.S.22
Muñoz, M.23
Palacios, E.24
Sanchez, E.25
Sloutsky, A.26
Becerra, M.C.27
more..
-
5
-
-
36048947771
-
Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis
-
Kim H-R, Hwang SS, Kim HJ, Lee SM, Yoo C-G, Kim YW, Han SK, Shim Y-S, Yim J-J. 2007. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin. Infect. Dis. 45:1290-1295.
-
(2007)
Clin. Infect. Dis.
, vol.45
, pp. 1290-1295
-
-
Kim, H.-R.1
Hwang, S.S.2
Kim, H.J.3
Lee, S.M.4
Yoo, C.-G.5
Kim, Y.W.6
Han, S.K.7
Shim, Y.-S.8
Yim, J.-J.9
-
6
-
-
55549142208
-
Multidrug-and extensively drug-resistant tuberculosis, Germany
-
Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C. 2008. Multidrug-and extensively drug-resistant tuberculosis, Germany. Emerg. Infect. Dis. 14:1700-1706.
-
(2008)
Emerg. Infect. Dis.
, vol.14
, pp. 1700-1706
-
-
Eker, B.1
Ortmann, J.2
Migliori, G.B.3
Sotgiu, G.4
Muetterlein, R.5
Centis, R.6
Hoffmann, H.7
Kirsten, D.8
Schaberg, T.9
Ruesch-Gerdes, S.10
Lange, C.11
-
7
-
-
53749083142
-
Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: A retrospective cohort study
-
Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Atwood S, Mukherjee JS, Rich ML, Furin JJ, Nardell EA, Kim JY, Shin SS. 2008. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 372:1403-1409.
-
(2008)
Lancet
, vol.372
, pp. 1403-1409
-
-
Keshavjee, S.1
Gelmanova, I.Y.2
Farmer, P.E.3
Mishustin, S.P.4
Strelis, A.K.5
Andreev, Y.G.6
Pasechnikov, A.D.7
Atwood, S.8
Mukherjee, J.S.9
Rich, M.L.10
Furin, J.J.11
Nardell, E.A.12
Kim, J.Y.13
Shin, S.S.14
-
8
-
-
73849095144
-
HIV coinfection in multidrug-and extensively drug-resistant tuberculosis results in high early mortality
-
Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH. 2010. HIV coinfection in multidrug-and extensively drug-resistant tuberculosis results in high early mortality. Am. J. Respir. Crit. Care Med. 181:80-86.
-
(2010)
Am. J. Respir. Crit. Care Med.
, vol.181
, pp. 80-86
-
-
Gandhi, N.R.1
Shah, N.S.2
Andrews, J.R.3
Vella, V.4
Moll, A.P.5
Scott, M.6
Weissman, D.7
Marra, C.8
Lalloo, U.G.9
Friedland, G.H.10
-
10
-
-
84858657770
-
Linezolid for the treatment of complicated drug-resistant tuberculosis: A systematic review and meta-analysis
-
Cox H, Ford N. 2012. Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 16:447-454.
-
(2012)
Int. J. Tuberc. Lung Dis.
, vol.16
, pp. 447-454
-
-
Cox, H.1
Ford, N.2
-
11
-
-
84864518733
-
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: Systematic review and meta-analysis
-
Sotgiu G, Centis R, D'Ambrosio L, Alffenaar J-WC, Anger HA, Caminero JA, Castiglia P, Lorenzo SD, Ferrara G, Koh W-J, Schecter GF, Shim TS, Singla R, Skrahina A, Spanevello A, Udwadia ZF, Villar M, Zampogna E, ZellwegerJ-P, Zumla A, Migliori GB. 2012. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur. Respir. J. 40:1430-1442.
-
(2012)
Eur. Respir. J.
, vol.40
, pp. 1430-1442
-
-
Sotgiu, G.1
Centis, R.2
D'Ambrosio, L.3
J-Wc, A.4
Anger, H.A.5
Caminero, J.A.6
Castiglia, P.7
Lorenzo, S.D.8
Ferrara, G.9
Koh, W.-J.10
Schecter, G.F.11
Shim, T.S.12
Singla, R.13
Skrahina, A.14
Spanevello, A.15
Udwadia, Z.F.16
Villar, M.17
Zampogna, E.18
Zellweger, J.-P.19
Zumla, A.20
Migliori, G.B.21
more..
-
12
-
-
84872371975
-
Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: A systematic review and meta-analysis
-
Dey T, Brigden G, Cox H, Shubber Z, Cooke G, Ford N. 2013. Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis. J. Antimicrob. Chemother. 68: 284-293.
-
(2013)
J. Antimicrob. Chemother.
, vol.68
, pp. 284-293
-
-
Dey, T.1
Brigden, G.2
Cox, H.3
Shubber, Z.4
Cooke, G.5
Ford, N.6
-
13
-
-
84865541246
-
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: An individual patient data meta-analysis of 9,153 patients
-
Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang C-Y, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim H-R, Koh W-J, Lancaster J, Lange C, de Lange WCM, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park S, Pasvol G, Peña J, Pérez-Guzmán C, Quelapio MID, Ponce-de-Leon A, et al. 2012. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 9:e1001300.
-
(2012)
PLoS Med.
, vol.9
-
-
Ahuja, S.D.1
Ashkin, D.2
Avendano, M.3
Banerjee, R.4
Bauer, M.5
Bayona, J.N.6
Becerra, M.C.7
Benedetti, A.8
Burgos, M.9
Centis, R.10
Chan, E.D.11
Chiang, C.-Y.12
Cox, H.13
D'Ambrosio, L.14
Deriemer, K.15
Dung, N.H.16
Enarson, D.17
Falzon, D.18
Flanagan, K.19
Flood, J.20
Garcia-Garcia, M.L.21
Gandhi, N.22
Granich, R.M.23
Hollm-Delgado, M.G.24
Holtz, T.H.25
Iseman, M.D.26
Jarlsberg, L.G.27
Keshavjee, S.28
Kim, H.-R.29
Koh, W.-J.30
Lancaster, J.31
Lange, C.32
De Lange, W.C.M.33
Leimane, V.34
Leung, C.C.35
Li, J.36
Menzies, D.37
Migliori, G.B.38
Mishustin, S.P.39
Mitnick, C.D.40
Narita, M.41
O'Riordan, P.42
Pai, M.43
Palmero, D.44
Park, S.45
Pasvol, G.46
Peña, J.47
Pérez-Guzmán, C.48
Quelapio, M.I.D.49
Ponce-De-Leon, A.50
more..
-
14
-
-
1642448538
-
Using regression models in epidemiologic analysis, p 181-197
-
Oxford University Press, New York, NY
-
Rothman KJ. 2002. Using regression models in epidemiologic analysis, p 181-197. In Epidemiology: an introduction. Oxford University Press, New York, NY.
-
(2002)
Epidemiology: An Introduction
-
-
Rothman, K.J.1
-
16
-
-
1642420994
-
A modified Poisson regression approach to prospective studies with binary data
-
Zou G. 2004. A modified Poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 159:702-706.
-
(2004)
Am. J. Epidemiol.
, vol.159
, pp. 702-706
-
-
Zou, G.1
-
17
-
-
0003726404
-
-
Sage University Paper Series on Quantitative Applications in the Social Sciences, no. 07-106. Sage, Thousand Oaks, CA
-
Menard S. 1995. Applied logistic regression analysis. Sage University Paper Series on Quantitative Applications in the Social Sciences, no. 07-106. Sage, Thousand Oaks, CA.
-
(1995)
Applied Logistic Regression Analysis
-
-
Menard, S.1
-
18
-
-
33748314681
-
Object-oriented computation of sandwich estimators
-
Zeileis A. 2006. Object-oriented computation of sandwich estimators. J. Stat. Softw. 16:1-16. http://www.jstatsoft.org/v16/i09/.
-
(2006)
J. Stat. Softw.
, vol.16
, pp. 1-16
-
-
Zeileis, A.1
-
19
-
-
77958110812
-
Conducting meta-analyses in R with the metafor package
-
Viechtbauer W. 2010. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36:1-48. http://www.jstatsoft.org/v36/i03/.
-
(2010)
J. Stat. Softw.
, vol.36
, pp. 1-48
-
-
Viechtbauer, W.1
-
20
-
-
84889428993
-
Regression methods to detect publication and other bias in meta-analysis
-
Rothstein HR, Sutton AJ, Borenstein M (ed), John Wiley & Sons, Ltd, Chichester, United Kingdom
-
Sterne J, Egger M. 2005. Regression methods to detect publication and other bias in meta-analysis, p 99-110. In Rothstein HR, Sutton AJ, Borenstein M (ed), Publication bias in meta-analysis: prevention assessment and adjustments. John Wiley & Sons, Ltd, Chichester, United Kingdom.
-
(2005)
Publication Bias in Meta-analysis: Prevention Assessment and Adjustments
, pp. 99-110
-
-
Sterne, J.1
Egger, M.2
-
21
-
-
84867614599
-
Linezolid for treatment of chronic extensively drug-resistant tuberculosis
-
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon H-S, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee J-K, Lee D, Kim CT, Dartois V, Park S-K, Cho S-N, Barry CE, III. 2012. Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N. Engl. J. Med. 367:1508-1518.
-
(2012)
N. Engl. J. Med.
, vol.367
, pp. 1508-1518
-
-
Lee, M.1
Lee, J.2
Carroll, M.W.3
Choi, H.4
Min, S.5
Song, T.6
Via, L.E.7
Goldfeder, L.C.8
Kang, E.9
Jin, B.10
Park, H.11
Kwak, H.12
Kim, H.13
Jeon, H.-S.14
Jeong, I.15
Joh, J.S.16
Chen, R.Y.17
Olivier, K.N.18
Shaw, P.A.19
Follmann, D.20
Song, S.D.21
Lee, J.-K.22
Lee, D.23
Kim, C.T.24
Dartois, V.25
Park, S.-K.26
Cho, S.-N.27
Barry III, C.E.28
more..
-
22
-
-
24044461782
-
Linezolid for the treatment of multidrug-resistant tuberculosis
-
Fortún J, Martín-Dávila P, Navas E, Pérez-Elías MJ, Cobo J, Tato M, De la Pedrosa EG-G, Gómez-Mampaso E, Moreno S. 2005. Linezolid for the treatment of multidrug-resistant tuberculosis. J. Antimicrob. Chemother. 56:180-185.
-
(2005)
J. Antimicrob. Chemother.
, vol.56
, pp. 180-185
-
-
Fortún, J.1
Martín-Dávila, P.2
Navas, E.3
Pérez-Elías, M.J.4
Cobo, J.5
Tato, M.6
De La Pedrosa, E.G.-G.7
Gómez-Mampaso, E.8
Moreno, S.9
-
23
-
-
21444441075
-
Imipenem for treatment of tuberculosis in mice and humans
-
Chambers HF, Turner J, Schecter GF, Kawamura M, Hopewell PC. 2005. Imipenem for treatment of tuberculosis in mice and humans. Antimicrob. Agents Chemother. 49:2816-2821.
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 2816-2821
-
-
Chambers, H.F.1
Turner, J.2
Schecter, G.F.3
Kawamura, M.4
Hopewell, P.C.5
-
24
-
-
33747879490
-
Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis
-
Park I-N, Hong S-B, Oh Y-M, Kim M-N, Lim C-M, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS. 2006. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis. J. Antimicrob. Chemother. 58:701-704.
-
(2006)
J. Antimicrob. Chemother.
, vol.58
, pp. 701-704
-
-
Park, I.-N.1
Hong, S.-B.2
Oh, Y.-M.3
Kim, M.-N.4
Lim, C.-M.5
Lee, S.D.6
Koh, Y.7
Kim, W.S.8
Kim, D.S.9
Kim, W.D.10
Shim, T.S.11
-
25
-
-
59349113030
-
Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis
-
Nam H-S, Koh W-J, Kwon OJ, Cho S-N, Shim TS. 2009. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis. Int. J. Antimicrob. Agents 33:92-93.
-
(2009)
Int. J. Antimicrob. Agents
, vol.33
, pp. 92-93
-
-
Nam, H.-S.1
Koh, W.-J.2
Kwon, O.J.3
Cho, S.-N.4
Shim, T.S.5
-
26
-
-
72049096404
-
Linezolid in the treatment of multidrug-resistant tuberculosis
-
Schecter GF, Scott C, True L, Raftery A, Flood J, Mase S. 2010. Linezolid in the treatment of multidrug-resistant tuberculosis. Clin. Infect. Dis. 50: 49-55.
-
(2010)
Clin. Infect. Dis.
, vol.50
, pp. 49-55
-
-
Schecter, G.F.1
Scott, C.2
True, L.3
Raftery, A.4
Flood, J.5
Mase, S.6
-
27
-
-
77952564621
-
Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06
-
Anger HA, Dworkin F, Sharma S, Munsiff SS, Nilsen DM, Ahuja SD. 2010. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06. J. Antimicrob. Chemother. 65:775-783.
-
(2010)
J. Antimicrob. Chemother.
, vol.65
, pp. 775-783
-
-
Anger, H.A.1
Dworkin, F.2
Sharma, S.3
Munsiff, S.S.4
Nilsen, D.M.5
Ahuja, S.D.6
-
28
-
-
77949777990
-
Increasing pathomorphism of pulmonary tuberculosis: An observational study of slow clinical, microbiological and imaging response of lung tuberculosis to specific treatment. Which role for linezolid?
-
Manfredi R, Nanetti A, Dal Monte P, Calza L. 2009. Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological and imaging response of lung tuberculosis to specific treatment. Which role for linezolid? Braz. J. Infect. Dis. 13:297-303.
-
(2009)
Braz. J. Infect. Dis.
, vol.13
, pp. 297-303
-
-
Manfredi, R.1
Nanetti, A.2
Dal Monte, P.3
Calza, L.4
-
29
-
-
73449138438
-
Disseminated multiorgan MDR-TB resistant to virtually all first-line drugs
-
Sasse J, Teichmann D. 2009. Disseminated multiorgan MDR-TB resistant to virtually all first-line drugs. Eur. Respir. Rev. 18:291-294.
-
(2009)
Eur. Respir. Rev.
, vol.18
, pp. 291-294
-
-
Sasse, J.1
Teichmann, D.2
-
30
-
-
79959274035
-
Linezolid in the treatment of multidrug-resistant/extensively drugresistant tuberculosis in paediatric patients: Experience of a paediatric infectious diseases unit
-
Kjöllerström P, Brito MJ, Gouveia C, Ferreira G, Varandas L. 2011. Linezolid in the treatment of multidrug-resistant/extensively drugresistant tuberculosis in paediatric patients: experience of a paediatric infectious diseases unit. Scand. J. Infect. Dis. 43:556-559.
-
(2011)
Scand. J. Infect. Dis.
, vol.43
, pp. 556-559
-
-
Kjöllerström, P.1
Brito, M.J.2
Gouveia, C.3
Ferreira, G.4
Varandas, L.5
-
31
-
-
79959935423
-
Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB
-
Udwadia ZF, Sen T, Pinto LM. 2011. Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB. Recent Pat. Antiinfect. Drug Discov. 6:88-91.
-
(2011)
Recent Pat. Antiinfect. Drug Discov.
, vol.6
, pp. 88-91
-
-
Udwadia, Z.F.1
Sen, T.2
Pinto, L.M.3
-
32
-
-
80053082369
-
Linezolid safety, tolerability and efficacy to treat multidrug-and extensively drug-resistant tuberculosis
-
Villar M, Sotgiu G, D'Ambrosio L, Raymundo E, Fernandes L, Barbedo J, Diogo N, Lange C, Centis R, Migliori GB. 2011. Linezolid safety, tolerability and efficacy to treat multidrug-and extensively drug-resistant tuberculosis. Eur. Respir. J. 38:730-733.
-
(2011)
Eur. Respir. J.
, vol.38
, pp. 730-733
-
-
Villar, M.1
Sotgiu, G.2
D'Ambrosio, L.3
Raymundo, E.4
Fernandes, L.5
Barbedo, J.6
Diogo, N.7
Lange, C.8
Centis, R.9
Migliori, G.B.10
-
33
-
-
84855829764
-
Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine
-
Abbate E, Vescovo M, Natiello M, Cufré M, García A, Gonzalez Montaner P, Ambroggi M, Ritacco V, van Soolingen D. 2012. Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine. J. Antimicrob. Chemother. 67:473-477.
-
(2012)
J. Antimicrob. Chemother.
, vol.67
, pp. 473-477
-
-
Abbate, E.1
Vescovo, M.2
Natiello, M.3
Cufré, M.4
García, A.5
Gonzalez Montaner, P.6
Ambroggi, M.7
Ritacco, V.8
Van Soolingen, D.9
-
34
-
-
84867387568
-
Clofazimine in the treatment of multidrug-resistant tuberculosis
-
Xu H-B, Jiang R-H, Xiao H-P. 2012. Clofazimine in the treatment of multidrug-resistant tuberculosis. Clin. Microbiol. Infect. 18:1104-1110.
-
(2012)
Clin. Microbiol. Infect.
, vol.18
, pp. 1104-1110
-
-
Xu, H.-B.1
Jiang, R.-H.2
Xiao, H.-P.3
-
35
-
-
84858638496
-
Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis
-
Payen MC, De Wit S, Martin C, Sergysels R, Muylle I, Van Laethem Y, Clumeck N. 2012. Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis. Int. J. Tuberc. Lung Dis. 16:558-560.
-
(2012)
Int. J. Tuberc. Lung Dis.
, vol.16
, pp. 558-560
-
-
Payen, M.C.1
De Wit, S.2
Martin, C.3
Sergysels, R.4
Muylle, I.5
Van Laethem, Y.6
Clumeck, N.7
-
36
-
-
84860324887
-
On linezolid efficacy and tolerability
-
De Lorenzo S, Centis R, D'Ambrosio L, Sotgiu G, Migliori GB. 2012. On linezolid efficacy and tolerability. Eur. Respir. J. 39:770-772.
-
(2012)
Eur. Respir. J.
, vol.39
, pp. 770-772
-
-
De Lorenzo, S.1
Centis, R.2
D'Ambrosio, L.3
Sotgiu, G.4
Migliori, G.B.5
-
38
-
-
84870223120
-
Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children
-
Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS. 2012. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children. Int. J. Tuberc. Lung Dis. 16:1588-1593.
-
(2012)
Int. J. Tuberc. Lung Dis.
, vol.16
, pp. 1588-1593
-
-
Rose, P.C.1
Hallbauer, U.M.2
Seddon, J.A.3
Hesseling, A.C.4
Schaaf, H.S.5
-
39
-
-
84879026253
-
Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis? Antimicrob
-
Chang KC, Yew WW, Cheung SW, Leung CC, Tam CM, Chau CH, Wen PK, Chan RC. 2013. Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis? Antimicrob. Agents Chemother. 57:3445-3449.
-
(2013)
Agents Chemother.
, vol.57
, pp. 3445-3449
-
-
Chang, K.C.1
Yew, W.W.2
Cheung, S.W.3
Leung, C.C.4
Tam, C.M.5
Chau, C.H.6
Wen, P.K.7
Chan, R.C.8
-
40
-
-
69249137544
-
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
-
Migliori GB, Eker B, Richardson MD, Sotgiu G, Zellweger J-P, Skrahina A, Ortmann J, Girardi E, Hoffmann H, Besozzi G, Bevilacqua N, Kirsten D, Centis R, Lange C. 2009. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. Eur. Respir. J. 34:387-393.
-
(2009)
Eur. Respir. J.
, vol.34
, pp. 387-393
-
-
Migliori, G.B.1
Eker, B.2
Richardson, M.D.3
Sotgiu, G.4
Zellweger, J.-P.5
Skrahina, A.6
Ortmann, J.7
Girardi, E.8
Hoffmann, H.9
Besozzi, G.10
Bevilacqua, N.11
Kirsten, D.12
Centis, R.13
Lange, C.14
-
41
-
-
0036233695
-
Intrapulmonary pharmacokinetics of linezolid
-
Conte JE, Jr, Golden JA, Kipps J, Zurlinden E. 2002. Intrapulmonary pharmacokinetics of linezolid. Antimicrob. Agents Chemother. 46:1475-1480.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 1475-1480
-
-
Conte Jr., J.E.1
Golden, J.A.2
Kipps, J.3
Zurlinden, E.4
-
42
-
-
1242330011
-
Serum and sputum concentrations following the oral administration of linezolid in adult patients with cystic fibrosis
-
Saralaya D, Peckham DG, Hulme B, Tobin CM, Denton M, Conway S, Etherington C. 2004. Serum and sputum concentrations following the oral administration of linezolid in adult patients with cystic fibrosis. J. Antimicrob. Chemother. 53:325-328.
-
(2004)
J. Antimicrob. Chemother.
, vol.53
, pp. 325-328
-
-
Saralaya, D.1
Peckham, D.G.2
Hulme, B.3
Tobin, C.M.4
Denton, M.5
Conway, S.6
Etherington, C.7
-
43
-
-
84861172988
-
Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: Updated analysis of 51 patients
-
Koh W-J, Kang YR, Jeon K, Kwon OJ, Lyu J, Kim WS, Shim TS. 2012. Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients. J. Antimicrob. Chemother. 67:1503-1507.
-
(2012)
J. Antimicrob. Chemother.
, vol.67
, pp. 1503-1507
-
-
Koh, W.-J.1
Kang, Y.R.2
Jeon, K.3
Kwon, O.J.4
Lyu, J.5
Kim, W.S.6
Shim, T.S.7
-
44
-
-
1642351934
-
Mutant prevention concentration: Comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis
-
Rodríguez JC, Cebrián L, López M, Ruiz M, Jiménez I, Royo G. 2004. Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis. J. Antimicrob. Chemother. 53:441-444.
-
(2004)
J. Antimicrob. Chemother.
, vol.53
, pp. 441-444
-
-
Rodríguez, J.C.1
Cebrián, L.2
López, M.3
Ruiz, M.4
Jiménez, I.5
Royo, G.6
-
45
-
-
44449177016
-
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years
-
Huang T-S, Liu Y-C, Sy C-L, Chen Y-S, Tu H-Z, Chen B-C. 2008. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years. Antimicrob. Agents Chemother. 52:2226-2227.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 2226-2227
-
-
Huang, T.-S.1
Liu, Y.-C.2
Sy, C.-L.3
Chen, Y.-S.4
Tu, H.-Z.5
Chen, B.-C.6
-
46
-
-
84870747517
-
Efficacy and safety of meropenem/clavunate added to linezolid containing regimens in the treatment of M/XDR-TB
-
De Lorenzo S, Alffenaar JW, Sotgiu G, Centis R, D'Ambrosio L, Tiberi S, Bolhuis MS, van Altena R, Viggiani P, Piana A, Spanevello A, Migliori GB. 2013. Efficacy and safety of meropenem/clavunate added to linezolid containing regimens in the treatment of M/XDR-TB. Eur. Respir. J. 41:1386-1392.
-
(2013)
Eur. Respir. J.
, vol.41
, pp. 1386-1392
-
-
De Lorenzo, S.1
Alffenaar, J.W.2
Sotgiu, G.3
Centis, R.4
D'Ambrosio, L.5
Tiberi, S.6
Bolhuis, M.S.7
Van Altena, R.8
Viggiani, P.9
Piana, A.10
Spanevello, A.11
Migliori, G.B.12
-
47
-
-
0031916549
-
Activity of amoxicillin/clavulanate in patients with tuberculosis
-
Chambers HF, Kocagöz T, Sipit T, Turner J, Hopewell PC. 1998. Activity of amoxicillin/clavulanate in patients with tuberculosis. Clin. Infect. Dis. 26:874-877.
-
(1998)
Clin. Infect. Dis.
, vol.26
, pp. 874-877
-
-
Chambers, H.F.1
Kocagöz, T.2
Sipit, T.3
Turner, J.4
Hopewell, P.C.5
-
48
-
-
0020589878
-
In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis
-
Cynamon MH, Palmer GS. 1983. In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 24:429-431.
-
(1983)
Antimicrob. Agents Chemother.
, vol.24
, pp. 429-431
-
-
Cynamon, M.H.1
Palmer, G.S.2
-
49
-
-
0025829552
-
Amoxicillinclavulanic acid for treating drug-resistant Mycobacterium tuberculosis
-
Nadler JP, Berger J, Nord JA, Cofsky R, Saxena M. 1991. Amoxicillinclavulanic acid for treating drug-resistant Mycobacterium tuberculosis. Chest 99:1025-1026.
-
(1991)
Chest
, vol.99
, pp. 1025-1026
-
-
Nadler, J.P.1
Berger, J.2
Nord, J.A.3
Cofsky, R.4
Saxena, M.5
-
50
-
-
0029018666
-
Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis
-
Cavalieri SJ, Biehle JR, Sanders WE, Jr. 1995. Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39:1542-1545.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 1542-1545
-
-
Cavalieri, S.J.1
Biehle, J.R.2
Sanders Jr., W.E.3
-
52
-
-
0030462751
-
Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: Potential use for initial therapy of freshly diagnosed tuberculosis
-
Amaral L, Kristiansen JE, Abebe LS, Millett W. 1996. Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. J. Antimicrob. Chemother. 38:1049-1053.
-
(1996)
J. Antimicrob. Chemother.
, vol.38
, pp. 1049-1053
-
-
Amaral, L.1
Kristiansen, J.E.2
Abebe, L.S.3
Millett, W.4
-
53
-
-
84859428822
-
Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections
-
Amaral L, Viveiros M. 2012. Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections. Int. J. Antimicrob. Agents 39:376-380.
-
(2012)
Int. J. Antimicrob. Agents
, vol.39
, pp. 376-380
-
-
Amaral, L.1
Viveiros, M.2
-
54
-
-
77952365008
-
Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis
-
Van Deun A, Maug AKJ, Salim MAH, Das PK, Sarker MR, Daru P, Rieder HL. 2010. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 182:684-692.
-
(2010)
Am. J. Respir. Crit. Care Med.
, vol.182
, pp. 684-692
-
-
Van Deun, A.1
Maug, A.K.J.2
Salim, M.A.H.3
Das, P.K.4
Sarker, M.R.5
Daru, P.6
Rieder, H.L.7
-
55
-
-
84894079423
-
Role of clofazimine in the treatment of multidrug-resistant tuberculosis: A retrospective observational cohort assessment
-
5 March. [Epub ahead of print.] doi:10.1093/jac/dks077
-
Xu HB, Jiang RH, Tang SJ, Li L, Xiao HP. 5 March 2012. Role of clofazimine in the treatment of multidrug-resistant tuberculosis: a retrospective observational cohort assessment. J. Antimicrob. Chemother. [Epub ahead of print.] doi:10.1093/jac/dks077.
-
(2012)
J. Antimicrob. Chemother
-
-
Xu, H.B.1
Jiang, R.H.2
Tang, S.J.3
Li, L.4
Xiao, H.P.5
|